Company Profile

Nellone Therapeutics Inc
Profile last edited on: 2/2/22      CAGE: 5WTY0      UEI: X42MJDLH51V5

Business Identifier: Regenerative medicine to restore injured tissue
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

11020 Solway School Rd Ste 101
Knoxville, TN 37931
   (865) 567-3351
Location: Single
Congr. District: 02
County: Knox

Public Profile

NellOne Therapeutics develops regenerative medicine solutions with a focus on tissue regeneration. The firm's primary solution, NELL1 protein, aims to improve outcomes for patients in the treatment of significant tissue damage as well as issues relating to inflammation. NELL1 reduces inflammation by controlling levels of pro inflammatory factors, increases cell and tissue survival under hypoxia, promotes cell division, assists in maturation of new tissues, and facitiliates stem cell recruitment to injury sites.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Bill Malkes -- CEO

  Cymbeline Culiat -- Co-founder and Chief Scientific Officer

  Shannon Eaker -- Chief Science Advisor

  Tracy Warren -- Co-Founder